Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1984-04-03
1986-04-15
Roberts, Elbert L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
A61K 3158
Patent
active
RE0321125
ABSTRACT:
A composition containing spironolactone in an amount effective to suppress excess androgenic activity. The spironolactone-containing composition is applied directly to the skin site afflicted with excess androgens.
REFERENCES:
patent: 3257390 (1966-06-01), Patchett
Shapiro et al., "Journal of Clinical Endocrinology and Metabolism, 51; p. 429 (1980).
Boisselle et al., "Fertility and Sterility; vol. 32, No. 3, Sep. 1979, pp. 276-279.
Ober et al., "Annals of Internal Medicine" 89 No. 5 (Part 1) Nov. 1978, pp. 543-544.
Chem. Abst. 83(21) 172,881t, An Abstract of the Publication in "Endocrinology", 97(1) pp. 52-58.
LandOfFree
Spironolactone-containing composition and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Spironolactone-containing composition and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spironolactone-containing composition and use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1431100